Because the antibody produced using the "anti-idiotypic" process closely resembles the original epitope of the antigen, these antibodies can be used to induce immune responses from cellular to antibody-antigen for a given antigen, e. g., TAA, when administered as a vaccine to a human.
Due to the close resemblance between the antibody produced via the "anti-idiotypic" method and the original epitope of the antigen, these antibodies can be used to induce an immune response that encompasses various stages, from cellular to antibody-antigen reactions for a specific antigen, such as TAA, when administered as a vaccine to a human.